These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37755152)

  • 1. Liver transplantation for post-COVID-19 cholangiopathy: A case series.
    Sambommatsu Y; Mouch C; Kulkarni AV; Bruno DA; Eslami M; Imai D; Lee SD; Khan AA; Sharma A; Saeed M; Cotterell AH; Levy MF; Morales MK; Montenovo MI; Rao PN; Reddy R; Menon B; Kumaran V
    Clin Transplant; 2023 Dec; 37(12):e15141. PubMed ID: 37755152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is post COVID-19 cholangiopathy an appropriate indication for liver transplantation?
    Kiyak M; Ayhan R; Yavuz M; Demirtas C; Çakmak S; Altunöz E; İpek S
    Rev Esp Enferm Dig; 2024 Jun; 116(6):336-337. PubMed ID: 37314132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection.
    Rela M; Rajakannu M; Veerankutty FH; Vij M; Rammohan A
    Am J Transplant; 2022 Dec; 22(12):3143-3145. PubMed ID: 35929565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.
    Durazo FA; Nicholas AA; Mahaffey JJ; Sova S; Evans JJ; Trivella JP; Loy V; Kim J; Zimmerman MA; Hong JC
    Transplant Proc; 2021 May; 53(4):1132-1137. PubMed ID: 33846012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Faruqui S; Okoli FC; Olsen SK; Feldman DM; Kalia HS; Park JS; Stanca CM; Figueroa Diaz V; Yuan S; Dagher NN; Sarkar SA; Theise ND; Kim S; Shanbhogue K; Jacobson IM
    Am J Gastroenterol; 2021 Jul; 116(7):1414-1425. PubMed ID: 33993134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for post-COVID-19 sclerosing cholangitis.
    Lee A; Wein AN; Doyle MBM; Chapman WC
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34446515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
    Bartoli A; Cursaro C; Seferi H; Andreone P
    Hepat Med; 2023; 15():93-112. PubMed ID: 37547355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplant after SARS-CoV-2 infection: A systematic review.
    Nacif LS; Fernandes MR; Waisberg DR; Pinheiro RS; Rocha-Santos V; Galvão F; Andraus W; Carneiro-D'Albuquerque L
    Clinics (Sao Paulo); 2022; 77():100042. PubMed ID: 35870265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and outcomes of deceased donor SARS-CoV-2-positive organs for solid organ transplantation in the United States.
    Schold JD; Koval CE; Wee A; Eltemamy M; Poggio ED
    Am J Transplant; 2022 Sep; 22(9):2217-2227. PubMed ID: 35730252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome.
    Hayashi K; Ito Y; Yamane R; Yoshizaki M; Matsushita K; Kajikawa G; Kozawa T; Mizutani T; Shimizu Y; Nagano K; Tachi K; Yoshioka K; Goto H
    Clin J Gastroenterol; 2021 Jun; 14(3):842-845. PubMed ID: 33675512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living Donor Liver Transplantation During the COVID-19 Pandemic: an Evolving Challenge.
    Bhatti ABH; Nazish M; Khan NY; Manan F; Zia HH; Ilyas A; Ishtiaq W; Khan NA
    J Gastrointest Surg; 2021 Dec; 25(12):3092-3098. PubMed ID: 34131867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
    Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
    Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
    Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
    Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
    Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence for predicting survival following deceased donor liver transplantation: Retrospective multi-center study.
    Yu YD; Lee KS; Man Kim J; Ryu JH; Lee JG; Lee KW; Kim BW; Kim DS;
    Int J Surg; 2022 Sep; 105():106838. PubMed ID: 36028137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-COVID-19 Cholestasis: A Case Series and Review of Literature.
    Kulkarni AV; Khelgi A; Sekaran A; Reddy R; Sharma M; Tirumalle S; Gora BA; Somireddy A; Reddy J; Menon B; Reddy DN; Rao NP
    J Clin Exp Hepatol; 2022; 12(6):1580-1590. PubMed ID: 35719861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35.
    Yun SO; Kim J; Rhu J; Choi GS; Joh JW
    J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1293-1303. PubMed ID: 37799067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good outcome of living donor liver transplantation for severe alcoholic hepatitis not responding to medical management: A single center experience of 39 patients.
    Choudhary NS; Saigal S; Gautam D; Saraf N; Rastogi A; Goja S; Bhangui P; Thiagrajan S; Yadav SK; Mehrotra S; Rastogi V; Soin AS
    Alcohol; 2019 Jun; 77():27-30. PubMed ID: 30772702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.